Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 766 AL 780

Seeking Traditional Health Practitioners and Use of Complementary/Alternative Medicines in the Management of Movement Disorders in Africa: A Multicenter Continental Study

Shalash A, Roushdy T, Ben Sassi S, Ojo O, Jamnagerwalla Y, Sheikh AO, Mecheri Y, Fall M, Gams Massi D, Rasaholiarison N, Sokhi D, Ponte NK, Mwemezi P, Esam M, Marzouki B, Agabi O, Zidan T, Serradj F, Magnerou AM, Touna HE, Lemdaoui I, Marcellin B, Fekraoui BS, Razafimahefa J, Mouandza E, Zouari R, Rachdi A, Diop AM, Kahwagi J, Dekker MCJ, Hooker J, Okubadejo NU, Hamid E.

Mov Disord. 2026 Jun;41(6):1502-1515. doi: 10.1002/mds.70280. Epub 2026 Mar 15.

Parkinson's Disease in Times of War: Gaps in Knowledge and Emerging Controversies

Salari M, Etemadifar M, Soleimani S.

Mov Disord. 2026 Jun;41(6):1362-1369. doi: 10.1002/mds.70272. Epub 2026 Mar 17.

Bridging the gap to clinical translation: the advanced role of PET molecular imaging in stem cell therapy

Cen P, Jin C, Wang J, Zhou R, Zhong Y, Tian M, Zhang H.

Eur J Nucl Med Mol Imaging. 2026 Jul;53(8):4803-4806. doi: 10.1007/s00259-026-07859-6. Epub 2026 Mar 25.

Multiomic and Longitudinal Dissection of Immune Dynamics Associated with Parkinsonism after Ciltacabtagene Autoleucel Therapy

Kadel SK, Scheller L, Leipold AM, Krammer T, Raskó T, Alb M, Weis P, Leberzammer M, Schmitt F, Stetter C, Tamamushi Y, Köck A, Köberle P, Reich M, Musacchio T, Doppler K, Sommer C, Cebulla N, McFleder R, Ip CW, Volkmann J, Kallius M, Serfling SE, Hartrampf PE, Buck AK, Pande A, Löffler D, Gernert M, Duell J, Topp MS, Mersi J, Waldschmidt J, Einsele H, Hudecek M, Saliba AE, Rasche L, Kortüm KM.

Blood Cancer Discov. 2026 Jul 1;7(4):544-557. doi: 10.1158/2643-3230.BCD-25-0278.

Perspective: Depression in Persons with Parkinson's Disease

Leentjens AFG, Pontone GM.

Mov Disord. 2026 Jun;41(6):1355-1361. doi: 10.1002/mds.70285. Epub 2026 Mar 31.

Presynaptic dopaminergic imaging as a neurodegeneration staging biomarker in the alpha-synucleinopathy continuum

Arnaldi D, Mattioli P, Orso B, Raffa S, Lanfranchi F, Massa F, Iranzo A, Perissinotti A, Niñerola-Baizán A, Gaig C, Serradell M, Montini A, Mayà G, Muñoz-Lopetegi A, Liguori C, Fernandes M, Placidi F, Chiaravalloti A, Šonka K, Dušek P, Zogala D, Trnka J, Boeve BF, Miyagawa T, Lowe VJ, Miyamoto T, Miyamoto M, Puligheddu M, Figorilli M, Serra A, Hu MT, Klein JC, Bes F, Kunz D, Cochen De Cock V, De Verbizier D, Plazzi G, Antelmi E, Pizza F, Terzaghi M, Bossert I, Kulcsárová K, Garibotto V, Nicastro N, Lathuilière A, Bonanni L, Morbelli S, Roascio M, Arnulfo G, Pardini M.

Eur J Nucl Med Mol Imaging. 2026 Jun;53(7):4677-4688. doi: 10.1007/s00259-026-07834-1. Epub 2026 Apr 1.

Adaptive Deep Brain Stimulation for Parkinson's Disease: Navigating the Roadblocks to Clinical Implementation

Koeglsperger T, Scherer M, Kühn AA, Eusebio A, Fasano A, Krauss JK.

Mov Disord. 2026 Jun;41(6):1370-1383. doi: 10.1002/mds.70284. Epub 2026 Apr 1.

Unexpected Cortical Uptake on [ 18 F]FP-CIT PET/CT Revealing Delayed Brain Metastases From Renal Cell Carcinoma

Byun SJ, Choi B.

Clin Nucl Med. 2026 Jul 1;51(7):628-629. doi: 10.1097/RLU.0000000000006466. Epub 2026 Mar 31.

Is Levodopa Fueling Peripheral Nerve Damage? A Clinical and Neurophysiological Insight Into Polyneuropathy in Parkinson's Disease

Garasto E, Meksi K, Cerroni R, Mercuri NB, Stefani A, Rocchi C.

Muscle Nerve. 2026 Jul;74(1):22-29. doi: 10.1002/mus.70243. Epub 2026 Apr 11.

Prognosis in Parkinson's Disease: An Individual Patient Data Meta-Analysis of Six European Incidence Cohorts

Macleod AD, McLernon DJ, Camacho M, Williams-Gray CH, Lawson RA, Yarnall AJ, Bäckström D, Forsgren L, Maple-Grødem J, Alves G, Tysnes OB, Counsell CE; Parkinson's Incidence Cohorts Collaboration.

Mov Disord. 2026 Jul;41(7):1798-1811. doi: 10.1002/mds.70303. Epub 2026 Apr 11.

Comparison of Diagnostic Performance Between Standard Susceptibility Map-Weighted Imaging and Susceptibility Map-Weighted Imaging Reconstructed From Clinical SWI and Neuromelanin MRI in Early Parkinson's Disease

Lee S, Sim Y, Youn J, Kim EY, Moon SH, Baek SY, Sohn B.

J Magn Reson Imaging. 2026 Aug;64(2):404-412. doi: 10.1002/jmri.70332. Epub 2026 Apr 15.

Self-Controlled Feedback on Motor Learning and Neuroplastic Changes in People With Parkinson Disease

Lim DJ, Tai CH, Chen SY, Huang CY, Lee YY.

J Neurol Phys Ther. 2026 Jul 1;50(3):166-173. doi: 10.1097/NPT.0000000000000553. Epub 2026 Apr 17.

Long-term follow up of opicapone as add-on to levodopa in Parkinson's patients without motor fluctuations

Ferreira JJ, Rascol O, Stocchi F, Antonini A, Moreira J, Fonseca MM, Rocha JF, Brigas HC, Holenz J, Poewe W; Epsilon Study investigators.

J Parkinsons Dis. 2026 Jun;16(4):797-802. doi: 10.1177/1877718X261436957. Epub 2026 Apr 17.

SARM1 executes neuronal parthanatos and promotes excitotoxic cell death

Wu T, Yuan L, Sasaki Y, Chen SJ, Buchser W, Bloom AJ, DiAntonio A, Milbrandt J.

Neuron. 2026 Aug 19;114(16):2975-2986.e5. doi: 10.1016/j.neuron.2026.03.027. Epub 2026 Apr 16.

Feasibility and validity of the D-Cog: A novel digital spatial working memory test for dementia assessment

Musaeus CS, Curnin CB, Muthupalaniappan S, Friedman G, Aslarus I, Hayashi T, Smith MA, Press DZ.

J Alzheimers Dis. 2026 Jun;111(3):1309-1316. doi: 10.1177/13872877261442078. Epub 2026 Apr 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias